IRIS
POMELLA, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 288
AS - Asia 247
EU - Europa 226
AF - Africa 1
OC - Oceania 1
Totale 763
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 287
SG - Singapore 207
IT - Italia 97
RU - Federazione Russa 45
IE - Irlanda 27
ID - Indonesia 23
DE - Germania 12
GB - Regno Unito 12
FR - Francia 10
FI - Finlandia 7
CN - Cina 6
NL - Olanda 5
IN - India 3
PH - Filippine 3
GR - Grecia 2
HK - Hong Kong 2
IR - Iran 2
LV - Lettonia 2
AU - Australia 1
CA - Canada 1
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
PL - Polonia 1
RS - Serbia 1
SE - Svezia 1
Totale 763
Salva come PNG Salva come JPEG
Città #
Singapore 188
New York 53
Santa Clara 38
Rome 33
Dublin 27
Jakarta 23
Council Bluffs 16
Moscow 11
Mülheim 8
Center 7
London 7
Ashburn 5
Ayn 5
Lappeenranta 5
Colorado Springs 4
Foggia 4
Amsterdam 3
Bari 3
Manila 3
Palermo 3
Pune 3
Ardea 2
Beijing 2
Bitonto 2
Columbus 2
Gaeta 2
Guilford 2
Helsinki 2
Hong Kong 2
Kilburn 2
Los Angeles 2
Magenta 2
Milan 2
Mompeo 2
Paris 2
Pontedera 2
Rasht 2
Riga 2
Roseto degli Abruzzi 2
Salt Lake City 2
Shenzhen 2
Washington 2
Belgrade 1
Buffalo 1
Chiswick 1
Colombo 1
Dallas 1
Frankfurt am Main 1
Gunzenhausen 1
Houston 1
Las Vegas 1
Luxembourg 1
Munich 1
Nuremberg 1
Piraeus 1
Pittsburgh 1
Prescot 1
Santa Maria a Vico 1
Stockholm 1
Tallinn 1
Tempe 1
The Dalles 1
Trieste 1
Warsaw 1
Totale 513
Salva come PNG Salva come JPEG
Nome #
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 45
Radioresistance in rhabdomyosarcomas: much more than a question of dose 43
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 36
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas 35
Epigenetic remodelling in human hepatocellular carcinoma 34
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 32
null 32
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 32
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma 31
null 30
SNAI2-mediated repression of BIM protects rhabdomyosarcoma from ionizing radiation 30
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview 30
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting 27
null 27
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 26
Design of First-in-Class Dual {EZH}2/{HDAC} Inhibitor: biochemical activity and biological evaluation in cancer cells 25
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 25
KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma 23
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 22
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 22
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma 22
Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery 22
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects 22
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma 21
FAK Signaling in Rhabdomyosarcoma 21
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression 21
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma 20
New Insights on the Nuclear Functions and Targeting of FAK in Cancer 20
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma 20
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges 19
The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas 17
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma 16
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 15
Chemical genomics reveals histone deacetylases are required for core regulatory transcription 14
Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage 13
PAX3-FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability 12
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 12
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells 12
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor 12
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 8
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 4
Totale 950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.603
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023219 0 0 4 1 0 1 129 11 8 28 31 6
2023/2024144 4 2 6 4 10 52 23 5 7 3 2 26
2024/2025587 21 215 146 56 9 140 0 0 0 0 0 0
Totale 950